Thursday, February 2, 2006 • Vol 12, Issue 3

Support from the New Technology Development Fund enabled Dr. David Hockenbery to work with a small biotechnology company to identify optimized drug candidates related to discoveries in his lab. Rose Beer, senior licensing associate, is the contact for the fund. Photo by Dean Forbes

• Bringing discoveries to life
  New Technology Development Fund bridges funding gap, provides critical support for projects with commercial, public-benefit applications
  
  
• Cancer and chemical exposure
  Epidemiologist Anneclaire De Roos finds possible link between contact with some persistent pollutants and risk of non-Hodgkin's lymphoma
  
  
• The challenge of nevirapine resistance
  Anthony Mwatha finds mothers and infants with some HIV subtypes show increased resistance to drug used to prevent perinatal transmission of HIV in developing countries
  
  

• Companions on the road of life and loss
  SCCA's Pastoral Care team celebrates two decades of helping patients, families and staff grieve and rejoice in the face of cancer
  
  
• Taking care of business
  25-year Center veteran Linda Billedo keeps records straight and money moving in Technology Transfer
  
  
• Astros' star honored at Safeco Field
  All-Star Craig Biggio receives Center's 2005 Hutch Award at annual luncheon
  
  

• Banks Warden heads strategic planning and development
  
  
• Hutchinson Center to televise Wood's health-policy lecture Feb. 10 in Sze
  
  
• Applications for aging and cancer pilot grants due March 27
  
  
• Next human-subjects research training is March 13 in Pelton
  
  
• Seattle Cancer Care Alliance staff celebrate fifth anniversary
  
  
• Join Weight Watchers at work; new session runs Feb. 15 through May 10
  
  
• Gala guild holds meeting to recruit new members Feb. 9 in Sze
  
  
• Say happy Valentine's Day with DNA
  
  

Credits